CARDIOME PHARMA CORP - COM NO PAR (CRME)

CUSIP: 14159U301

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / COM NO PAR
Total 13F shares
12,672,222
Share change
+62,982
Total reported value
$51,829,000
Price per share
$4.09
Number of holders
23
Value change
-$166,357
Number of buys
9
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 14159U301?
CUSIP 14159U301 identifies CRME - CARDIOME PHARMA CORP - COM NO PAR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CARDIOME PHARMA CORP - COM NO PAR (CRME) as of Q1 2016

As of 31 Mar 2016, CARDIOME PHARMA CORP - COM NO PAR (CRME) was held by 23 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,672,222 shares. The largest 10 holders included WESTFIELD CAPITAL MANAGEMENT CO LP, PUTNAM INVESTMENTS LLC, CLOUGH CAPITAL PARTNERS L P, Rock Springs Capital Management LP, FMR LLC, PointState Capital LP, AlphaOne Investment Services, LLC, TURNER INVESTMENTS, L.P., MACKENZIE FINANCIAL CORP, and RENAISSANCE TECHNOLOGIES LLC. This page lists 23 institutional shareholders reporting positions in this security for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.